Managing the GLP-1 Group Costs: How South Georgia Small Businesses Can Control 2026 Benefits

South Georgia business owners are noticing a significant shift in their health insurance renewals in 2026. With small group premiums seeing a median increase of roughly 11%, and the primary driver of conversation is cost management

While several factors contribute to these rising rates, one of the most significant and new budget-shifters is the skyrocketing demand for GLP-1 medications (such as Ozempic, Wegovy, and Zepbound).

At H&H Insurance Solutions, we believe managing these costs requires a shift from passive renewals to active strategic planning. Understanding the mechanics of how these medications impact a group plan is the first step in maintaining a sustainable benefits package for a local workforce.

The Financial Reality of GLP-1 Coverage

GLP-1 drugs have revolutionized the treatment of diabetes and obesity. For employees, these medications can be life-changing, leading to better long-term health and happiness of employees. However, for a small to medium-sized business, the high monthly cost of these specialty drugs can quickly cause premiums to increase.

As a broker based in Valdosta, we see the direct impact these national pharmaceutical trends have on our local South Georgia economy. When a plan experiences a high volume of specialty drug claims, it often results in double-digit rate increases that can strain a small business’s operating budget.

How H&H Helps You Navigate Rising Costs

We don’t believe in “one-size-fits-all” insurance. Our role is to act as your strategic partner to find a balance between comprehensive coverage and budget-friendly premiums. Here’s how we tackle the specialty drug challenge:

• Alternative Funding Models: For some businesses, moving toward models like the Georgia Chamber SMART Plan or an ICHRA might provide more stability against the volatility of drug costs.
• Custom Plan Design: We help you evaluate “defined contribution” models, such as an ICHRA, which allow you to set a fixed budget for benefits while employees choose plans on the Georgia Access marketplace.
• Shopping the Marketplace: Because we are independent and affiliated with a variety of carriers, we can shop the entire Georgia marketplace to find the most competitive rates for your specific group size.
• Pharmacy Benefit Management: We look at how different carriers manage their drug formularies, ensuring your employees have access to necessary medicine without unnecessary waste.

Looking Ahead: Preparing for the 2027 Specialty Drug Expansion

This trend is not expected to plateau in the short term. Looking toward 2027, experts anticipate the GLP-1 market will become larger as these drugs receive FDA approval for additional uses, such as treating sleep apnea and cardiovascular disease. Furthermore, a massive “pipeline” of new medications is on the horizon, including oral versions of these drugs and “triple agonist” medications like retatrutide (a next-generation ‘3-in-1’ drug currently in late-stage trials), which may be even more effective—and potentially more expensive than current options.

Small businesses should expect continued cost pressure throughout the next 24 months. As competition between pharmaceutical companies increases, we may eventually see more aggressive rebates or price adjustments, but for now, the primary strategy for employers must remain focused on plan design and utilization management to avoid unsustainable budget spikes.

Have questions or ready to get started managing your group costs?

Give us a call, or use our contact us page to reach out.